MX2022011858A - Composiciones que comprenden uno o mas hmo con un nucleo de lacnac-lac. - Google Patents

Composiciones que comprenden uno o mas hmo con un nucleo de lacnac-lac.

Info

Publication number
MX2022011858A
MX2022011858A MX2022011858A MX2022011858A MX2022011858A MX 2022011858 A MX2022011858 A MX 2022011858A MX 2022011858 A MX2022011858 A MX 2022011858A MX 2022011858 A MX2022011858 A MX 2022011858A MX 2022011858 A MX2022011858 A MX 2022011858A
Authority
MX
Mexico
Prior art keywords
sub
formula
lacnac
hmo
lac
Prior art date
Application number
MX2022011858A
Other languages
English (en)
Inventor
Vassilios Triantis
Original Assignee
Frieslandcampina Nederland Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Frieslandcampina Nederland Bv filed Critical Frieslandcampina Nederland Bv
Publication of MX2022011858A publication Critical patent/MX2022011858A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/702—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/738—Cross-linked polysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Abstract

Una composición sintética que comprende uno o más compuestos de acuerdo con la fórmula 1, o una sal, solvato o éster farmacéuticamente aceptable de estos, para su uso en la modulación de uno o más de: i. el nivel de colesterol; ii. lipólisis; iii. la captación de glucosa; iv. actividad del receptor CD36; donde el compuesto de Fórmula 1 es Yn?D-Gal-ß1?3-(Ym?)(Xp?D-GlcNAc-ß1?3-D-Gal-ß1?4-(Xq?)-D-Glc Fórmula 1 donde: X es a-L-Fucosa (a-L-Fuc), Y es ácido N-acetil-D-neuramínico (Neu5Ac-a-2-) n, m, p, q indican el número de residuos monosacarídicos presentes en el compuesto de fórmula 1 y n es 0 o 1; m es 0 o 1; p es 0 o 1; q es 0 o 1; y n+m+p+q = 1.
MX2022011858A 2020-03-25 2021-03-24 Composiciones que comprenden uno o mas hmo con un nucleo de lacnac-lac. MX2022011858A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP20165487 2020-03-25
PCT/EP2021/057530 WO2021191251A1 (en) 2020-03-25 2021-03-24 COMPOSITIONS COMPRISING ONE OR MORE HMO'S WITH A CORE OF LacNAc-Lac

Publications (1)

Publication Number Publication Date
MX2022011858A true MX2022011858A (es) 2023-01-04

Family

ID=69960559

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2022011858A MX2022011858A (es) 2020-03-25 2021-03-24 Composiciones que comprenden uno o mas hmo con un nucleo de lacnac-lac.

Country Status (5)

Country Link
EP (1) EP4125934A1 (es)
CN (1) CN115335063A (es)
AU (1) AU2021241800A1 (es)
MX (1) MX2022011858A (es)
WO (1) WO2021191251A1 (es)

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8197872B2 (en) 2007-05-17 2012-06-12 The Regents Of The University Of California Human milk oligosaccharides to promote growth of beneficial gut bacteria
CA3098403C (en) 2011-02-16 2022-05-10 Glycosyn LLC Biosynthesis of human milk oligosaccharides in engineered bacteria
ES2891731T3 (es) * 2013-05-22 2022-01-31 Glycom As Mezcla sintética de oligosacáridos para el tratamiento de la microbiota de un mamífero
US10835544B2 (en) * 2014-12-08 2020-11-17 Glycom A/S Synthetic composition for regulating satiety
WO2017215721A1 (en) * 2016-06-15 2017-12-21 Glycom A/S Synthetic compositions comprising human milk oligosaccharides for use γν the prevention and treatment of disorders
CN109498633A (zh) * 2017-09-15 2019-03-22 武汉朗来科技发展有限公司 糖类化合物的医药用途
WO2019169188A1 (en) * 2018-02-28 2019-09-06 The Regents Of The University Of California Methods and therapies for treating atherosclerosis and/or hyperlipidemia using oligosaccharides

Also Published As

Publication number Publication date
AU2021241800A1 (en) 2022-08-04
CN115335063A (zh) 2022-11-11
WO2021191251A1 (en) 2021-09-30
EP4125934A1 (en) 2023-02-08

Similar Documents

Publication Publication Date Title
CA2334342A1 (en) Epothilone derivatives and their synthesis and use
AU6277396A (en) Prevention and treatment of cardiovascular pathologies with tamoxifen analogues
RU2000132188A (ru) Производные эпотилонов, их синтез и применение
BR9916790A (pt) Uso de um composto, composto, processo para amanufatura do mesmo, composição farmacêtica, e,método para produzir um efeito de dano vascularem um animal de sangue quente
EP2292593A3 (en) Carbamic acid compounds comprising a sulfonamide linkage as HDAC inhibitors
HUP0301427A2 (hu) Fotokemoterápiában alkalmazható fotoszenzitizáló, 5-aminolevulinsavészterek azokat tartalmazó gyógyszerkészítmények és alkalmazásuk
MX2011012544A (es) Oxazolidinona que contiene compuestos de dimero, composiciones y metodos para elaborar y usar.
DE3160036D1 (en) Substituted imidazoles, their preparation and pharmaceutical compositions containing the same
ATE19878T1 (de) Benzimidazol-derivate, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammensetzungen.
MA29412B1 (fr) Derives d'acetylene
DK2041133T3 (da) Derivater af imadazol [1,2-A] pyridine-2-carboxamider, fremstilling deraf og anvendelse deraf i terapeutik
EA201290520A1 (ru) Производные дифенилпиразолопиридинов, их получение и применение в качестве модуляторов нуклеарного рецептора not
ZA200502820B (en) Bitumen composition
RU2008112884A (ru) Агент для снижения инсулинорезистентности
MY124727A (en) Tri-substituted phenyl derivatives and analogues.
FI823871L (fi) Foerfarande foer framstaellning av substituerade imidazolderivat
RU2003134629A (ru) Соединения цефема
MX2022011858A (es) Composiciones que comprenden uno o mas hmo con un nucleo de lacnac-lac.
NO20001887L (no) Preparat til behandling av trevirke
JP2004529960A5 (es)
ES476866A1 (es) Procedimiento de preparacion de isomeros a de nuevos deriva-dos de 20,21-dinoreburnamenina.
JP2004518639A5 (es)
RU93004472A (ru) Полициклические биоцидные соединения и композиция на их основе
ES450128A1 (es) Metodo para preparar un ester de acido behenico.
BRPI0412643A (pt) composto, sal farmaceuticamente aceitável de um composto, composição farmacêutica, método de tratamento, prevenção ou melhoria de infecções em um paciente, uso de um composto, e, método de preparação de um composto